221 related articles for article (PubMed ID: 29123483)
1. Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram.
Chakroborty S; Geisbush TR; Dale E; Pehrson AL; Sánchez C; West AR
Front Pharmacol; 2017; 8():764. PubMed ID: 29123483
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
Riga MS; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
[TBL] [Abstract][Full Text] [Related]
3. Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT
Okada M; Okubo R; Fukuyama K
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835640
[TBL] [Abstract][Full Text] [Related]
4. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C
Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991
[TBL] [Abstract][Full Text] [Related]
5. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex.
Riga MS; Teruel-Martí V; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2017 Feb; 113(Pt A):148-155. PubMed ID: 27671324
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain.
El Mansari M; Lecours M; Blier P
Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528
[TBL] [Abstract][Full Text] [Related]
7. Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.
Okada M; Matsumoto R; Yamamoto Y; Fukuyama K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572981
[TBL] [Abstract][Full Text] [Related]
8. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL
Eur Neuropsychopharmacol; 2014 Jan; 24(1):148-59. PubMed ID: 24284262
[TBL] [Abstract][Full Text] [Related]
9. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
[TBL] [Abstract][Full Text] [Related]
10. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C
Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338
[TBL] [Abstract][Full Text] [Related]
11. Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats.
Wallace A; Pehrson AL; Sánchez C; Morilak DA
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1695-706. PubMed ID: 24852131
[TBL] [Abstract][Full Text] [Related]
12. In vivo electrophysiological study of the targeting of 5-HT
Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T
Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812
[TBL] [Abstract][Full Text] [Related]
13. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C
J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043
[TBL] [Abstract][Full Text] [Related]
14. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
[TBL] [Abstract][Full Text] [Related]
15. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
Sanchez C; Asin KE; Artigas F
Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
[TBL] [Abstract][Full Text] [Related]
16. Electrical stimulation of the hippocampal fimbria facilitates neuronal nitric oxide synthase activity in the medial shell of the rat nucleus accumbens: Modulation by dopamine D1 and D2 receptor activation.
Hoque KE; Blume SR; Sammut S; West AR
Neuropharmacology; 2017 Nov; 126():151-157. PubMed ID: 28887183
[TBL] [Abstract][Full Text] [Related]
17. Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats.
Riga MS; Sanchez C; Celada P; Artigas F
Neuropharmacology; 2020 Nov; 178():108238. PubMed ID: 32750446
[TBL] [Abstract][Full Text] [Related]
18. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
[TBL] [Abstract][Full Text] [Related]
19. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
[TBL] [Abstract][Full Text] [Related]
20. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.
Artigas F; Bortolozzi A; Celada P
Eur Neuropsychopharmacol; 2018 Apr; 28(4):445-456. PubMed ID: 29174531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
